NTLA logo
NTLA

Intellia Therapeutics Inc

Biotechnology

Intellia Therapeutics Inc (NTLA) Earnings

Last reported
April 30, 2026
EPS estimate
-$0.94
EPS actual
Revenue est.
$14.8M
Revenue actual